Efficacy of Drug and Risk Behavior Counseling Intervention Among Injecting Drug Users at Opioid Substitution Treatment
Substance Use Disorders
About this trial
This is an interventional treatment trial for Substance Use Disorders focused on measuring Behavior drug and risk reduction counseling, Heroin, Addiction treatment, Randomization, Treatment effect
Eligibility Criteria
Inclusion Criteria:
- Enrollment in opioid substitution treatment
- Injected heroin within past 30 days by self-report, documented by "tracks" or puncture marks
- 20 or more years of age
- Meets ICD-10 criteria for opiates dependence with physiologic features
- Agrees to keep bi-weekly appointments if selected
- Current address within Taipei and Keelung, and not planning to move
- Willingness and ability to give informed consent and otherwise participate
- Provision of adequate locator information
Exclusion Criteria:
- Clinically significant cognitive impairment, schizophrenia, paranoid disorder, bipolar disorder
- Advanced neurological, cardiovascular, renal, or other medical disorder that is likely to impair or make hazardous patient's ability to participate
- Physiologically dependent on alcohol, benzodiazepines or other sedative type drugs
- Concurrent participation in another treatment study
- Planning to enter inpatient or residential treatment within next year
- Pending legal charges with likely incarceration within next 12 months
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Other
BDRC
TAU
At the time of assignment to the counseling intervention arm of the study, there will be an initial meeting between the subject and the assigned counselor. As described in the counseling manual, this initial session is designed to introduce the counselor, review the purpose and expectations of counseling, review the rules of confidentiality, agree on attendance times and rescheduling rules, and to begin to collect information from the participant on their drug use and risk behaviors. Behavioral contracting is a key component to this counseling approach.
Patients receive some HIV risk education for the enrollment; after that, health education is delivered irregularly (1-2 times a month or none), based on the patient's needs.